Davies Peter E J, Davis Garry J, Dodd Tom, Selva Dinesh
Department of Ophthalmology, Royal Adelaide Hospital, South Australia, Australia.
Clin Exp Ophthalmol. 2002 Aug;30(4):281-3. doi: 10.1046/j.1442-9071.2002.00542.x.
Haemangiopericytoma (HPC) of the orbit is a rare tumour occurring in all age groups and presenting with slowly progressive proptosis, ocular motility impairment and visual loss. Although most are benign tumours that are resectable at diagnosis, one-third of these tumours demonstrate malignant features and recur locally or metastasize, usually with a fatal outcome. In 1995, a morphologically unique variant, termed lipomatous haemangiopericytoma (L-HPC), was described. Only one case has been reported previously arising in the orbit. In this paper, a case is reported of L-HPC occurring in the orbit and consider the prognostic implications of this HPC variant.
眼眶血管外皮细胞瘤(HPC)是一种罕见肿瘤,可发生于所有年龄组,表现为缓慢进展的眼球突出、眼球运动障碍和视力丧失。虽然大多数是良性肿瘤,诊断时可切除,但其中三分之一的肿瘤具有恶性特征,会局部复发或转移,通常导致致命后果。1995年,一种形态独特的变异型被描述为脂肪性血管外皮细胞瘤(L-HPC)。此前仅报道过1例发生于眼眶的病例。本文报告1例发生于眼眶的L-HPC病例,并探讨这种HPC变异型的预后意义。